The investigators want to understand the feasibility and acceptability of implementing COMPASS: Online Cognitive behavioural therapy (CBT) in routine NHS care for individuals with diabetes. People with type 1 or type 2 diabetes with co-morbid psychological distress will be invited to take part in a pre-post implementation study of COMPASS: Online CBT for managing depression and anxiety in context of Long-Term conditions (LTCs). Patients with diabetes who are also experiencing depression and/or anxiety and/or diabetes specific distress will be recruited from: Improving Access to Psychological therapies (IAPT) services or clinics within Guys and St Thomas National Health Service (NHS) trust (GSTT) in London, United Kingdom (UK).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
To assess the socio-demographic and clinical reach of COMPASS.
Timeframe: To be collected throughout the study duration (the study will run for an average of 12 months).
To assess the socio-demographic and clinical reach of COMPASS.
Timeframe: To be collected throughout the study duration (the study will run for an average of 12 months).
To assess the socio-demographic and clinical reach of COMPASS.
Timeframe: To be collected throughout the study duration (the study will run for an average of 12 months).
To explore the potential efficacy of COMPASS by examining pre-post change scores on self-reported mental health outcomes (listed below).
Timeframe: To be collected at baseline, 12 weeks and 6 month follow up.
To explore the potential efficacy of COMPASS by examining pre-post change scores on self-reported mental health outcomes (listed below).
Timeframe: To be collected at baseline, 12 weeks and 6 month follow up.
To explore the potential efficacy of COMPASS by examining pre-post change scores on self-reported mental health outcomes (listed below).
Timeframe: To be collected at baseline, 12 weeks and 6 month follow up.
To explore the potential efficacy of COMPASS by examining pre-post change scores on self-reported mental health outcomes (listed below).
Timeframe: To be collected at baseline, 12 weeks and 6 month follow up.
To explore the potential efficacy of COMPASS by examining pre-post change scores on self-reported psychosocial outcomes (listed below).
Timeframe: To be collected at baseline, 12 weeks and 6 month follow up.
To explore the potential efficacy of COMPASS by examining pre-post change scores on self-reported psychosocial outcomes (listed below).
Timeframe: To be collected at baseline, 12 weeks and 6 month follow up.
To explore the potential efficacy of COMPASS by examining pre-post change scores on self-reported psychosocial outcomes (listed below).
Timeframe: To be collected at baseline, 12 weeks and 6 month follow up.
To explore the potential efficacy of COMPASS by examining pre-post change scores on self-reported physical health outcomes (listed below).
Timeframe: To be collected at baseline, 12 weeks and 6 month follow up.
To examine barriers and facilitators to the adoption of COMPASS from the perspective of both staff and patients.
Timeframe: To be collected at 12 weeks.
To examine: i) number of patients who require digital support to use COMPASS ii) monthly referrals to COMPASS by staff.
Timeframe: To be collected at 12 weeks.
To assess the implementation of COMPASS in terms of patient adherence to COMPASS online sessions and number and duration of therapist support calls attended.
Timeframe: To be collected throughout the study duration (the study will run for an average of 12 months).